Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 9215857)

1.

Tumor cell growth is inhibited by suppressing metallothionein-I synthesis.

Takeda A, Hisada H, Okada S, Mata JE, Ebadi M, Iversen PL.

Cancer Lett. 1997 Jun 24;116(2):145-9.

PMID:
9215857
2.

Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.

Gong ZB, Liu JM, Li YM.

Hepatobiliary Pancreat Dis Int. 2005 Aug;4(3):433-6.

3.

Manipulation of metallothionein expression in the regenerating rat liver using antisense oligonucleotides.

Arora V, Iversen PL, Ebadi M.

Biochem Biophys Res Commun. 1998 May 29;246(3):711-8.

PMID:
9618277
4.
5.

Inhibition of DNA methyltransferase by antisense oligodeoxynucleotide modifies cell characteristics in gastric cancer cell lines.

Saikawa Y, Kubota T, Maeda S, Otani Y, Kumai K, Kitajima M.

Oncol Rep. 2004 Sep;12(3):527-31.

PMID:
15289832
6.

Suppression of tumorigenicity of human hepatocellular carcinoma cells by antisense oligonucleotide MZF-1.

Hsieh YH, Wu TT, Huang CY, Hsieh YS, Liu JY.

Chin J Physiol. 2007 Feb 28;50(1):9-15. Erratum in: Chin J Physiol. 2007 Apr 30;50(2):98.

PMID:
17593797
7.
8.

Effect of Nma on growth inhibition by TGF-betaa in human gastric carcinoma cell lines.

Sasaki T, Sasahira T, Shimura H, Ikeda S, Kuniyasu H.

Oncol Rep. 2004 Jun;11(6):1219-23.

PMID:
15138559
9.

Zinc depletion suppresses tumor growth in mice.

Takeda A, Goto K, Okada S.

Biol Trace Elem Res. 1997 Winter;59(1-3):23-9.

PMID:
9522043
10.

Growth reduction of a xenotransplanted human soft tissue sarcoma by MDM2 antisense therapy via implanted osmotic minipumps.

Würl P, Bartel F, Meye A, Kappler M, Bache M, Schmidt H, Schönfelder M, Taubert H.

Int J Oncol. 2002 May;20(5):1087-93.

PMID:
11956608
11.

Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.

Broaddus WC, Chen ZJ, Prabhu SS, Loudon WG, Gillies GT, Phillips LL, Fillmore H.

Neurosurgery. 1997 Oct;41(4):908-15.

PMID:
9316053
12.
14.

Effect of a metallothionein antisense oligonucleotide on embryo development.

Peters JM, Duncan JR, Wiley LM, Rucker RB, Keen CL.

Reprod Toxicol. 1995 Mar-Apr;9(2):123-30.

PMID:
7795322
15.

Oligonucleotide treatment of ras-induced tumors in nude mice.

Wickstrom E.

Mol Biotechnol. 2001 May;18(1):35-55. Review.

PMID:
11439698
16.
17.
18.

Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.

Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA, Zangemeister-Wittke U.

J Natl Cancer Inst. 1997 Jul 16;89(14):1027-36.

19.
20.

Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.

Uchida T, Gao JP, Wang C, Satoh T, Itoh I, Muramoto M, Hyodo T, Irie A, Akahoshi T, Jiang SX, Kameya T, Baba S.

Mol Urol. 2001 Summer;5(2):71-8.

PMID:
11690551
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk